These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of prostaglandins in Bartter's syndrome. Winterborn MH; Hewitt GJ; Mitchell MD Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882 [TBL] [Abstract][Full Text] [Related]
24. Prostaglandins and Bartter's syndrome. Dunn MJ Kidney Int; 1981 Jan; 19(1):86-102. PubMed ID: 7012423 [No Abstract] [Full Text] [Related]
25. Analysis of factors influencing the renin-aldosterone system in a patient with Bartter's syndrome. Sudan M; Stacy WK; Falls WF South Med J; 1979 Jul; 72(7):779-82. PubMed ID: 451681 [TBL] [Abstract][Full Text] [Related]
26. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors. Littlewood JM; Lee MR; Meadow SR Arch Dis Child; 1978 Jan; 53(1):43-8. PubMed ID: 415668 [TBL] [Abstract][Full Text] [Related]
27. Prostaglandin E excretion and inhibition of prostaglandin synthesis in Bartter's syndrome. Hsieh BS; Chen WY; Yen TS; Lai MS Taiwan Yi Xue Hui Za Zhi; 1978 Nov; 77(11):831-8. PubMed ID: 284093 [No Abstract] [Full Text] [Related]
28. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome]. Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335 [No Abstract] [Full Text] [Related]
29. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride. Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582 [TBL] [Abstract][Full Text] [Related]
30. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome. Ishikawa Y; Wada T Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898 [TBL] [Abstract][Full Text] [Related]
32. Studies on the pathogenesis of Bartter's syndrome. Baehler RW; Work J; Kotchen TA; McMorrow G; Guthrie G Am J Med; 1980 Dec; 69(6):933-8. PubMed ID: 7446558 [TBL] [Abstract][Full Text] [Related]
33. Responses to antiotensin II antagonist before and after treatment with indomethacin in Bartter's syndrome. Sasaki H; Okumura M; Asano T; Arakawa K; Kawasaki T Br Med J; 1977 Oct; 2(6093):995-6. PubMed ID: 922403 [No Abstract] [Full Text] [Related]
34. Captopril and Bartter's syndrome. Sasaki H; Okumura M; Kawasaki T Nephron; 1985; 41(3):303-4. PubMed ID: 3903530 [No Abstract] [Full Text] [Related]
35. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors. Rudin A; Aurell M; Hansson L; Westberg G Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Bartter FC; Gill JR; Frolich JC; Bowden RE; Hollifield JW; Radfar N; Keiser HR; Oates JA; Seyberth H; Taylor AA Trans Assoc Am Physicians; 1976; 89():77-91. PubMed ID: 828345 [TBL] [Abstract][Full Text] [Related]
39. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome. Griffing GT; Aurecchia SA; Sindler BH; Melby JC J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369 [TBL] [Abstract][Full Text] [Related]